Address
Email address
Phone number
Website
https://www.biocc.eeAvaleht | BioCC OÜBioCC tegeleb teadus- ja arendustööga kogu toiduahela ulatuses – alates loomaaretusest ja -söödast kuni kliiniliste katsete ja tervistedendavate toodete väljatöötamiseni. BioCC pakub nii mikrobioloogilisi- kui ka tootearendusteenuseid. Söödalisandite, toiduainete ja toidulisandite loomisel rakendatakse maailmatasemel innovaatilisi biotehnoloogilisi lahendusi.
Name
BioCC OÜ
Registry code
11077336
VAT number
EE100953471
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
04.01.2005 (19)
Financial year
01.01-31.12
Capital
6 000.00 €
Activity
72111 - Research and experimental development on biotechnology
476 374 €
3 011 €
1%
1 226 €
(estimate is approximate)
520 227 €
40
Submitted
No tax arrears
1%
0%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Osaühing Starter ST 10291079 | 6% - 348.00 EUR | - | - | Founder |
| Eesti Maaülikool 74001086 | 29% - 1 740.00 EUR | - | - | Founder |
| EESTI TÕULOOMAKASVATAJATE ÜHISTU 10064515 | 23% - 1 356.00 EUR | - | - | Founder |
| AS E-Piim Tootmine 12131598 | 23% - 1 356.00 EUR | - | - | |
| Tartu Ülikool 74001073 | 20% - 1 200.00 EUR | - | - | Founder |
| Ene Tammsaar 03.11.1954 (70) | - | Board member | - | |
| Ülle Jaakma 01.10.1957 (67) | - | - | Indirect ownership | |
| Jaanus Murakas 25.02.1968 (56) | - | - | - | Board member |
| Meeli Lindsaar 11.02.1978 (46) | - | - | - | Board member |
| Meelis Ots 10.08.1970 (54) | - | - | - | Board member |
| Pärt Peterson 18.04.1966 (58) | - | - | - | Board member |
| Tanel-Taavi Bulitko 12.01.1973 (51) | - | - | - | Board member |
| Üllas Jaaska 23.12.1954 (69) | - | - | - | Board member |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| NORDWISE BioTech OÜ 14877534 | 100% - 100 000.00 EUR | - | - | Founder |
| 2019 30.06.2020 | 2020 29.06.2021 | 2021 16.06.2022 | 2022 12.06.2023 | 2023 29.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 628 472 € | 517 305 € | 558 531 € | 570 548 € | 476 374 € |
| Net profit (loss) for the period | 43 983 € | 6 147 € | 10 365 € | 45 447 € | 3 011 € |
| Profit Margin | 7% | 1% | 2% | 8% | 1% |
| Current Assets | 880 737 € | 997 179 € | 1 196 330 € | 1 118 274 € | 1 039 677 € |
| Fixed Assets | 2 993 106 € | 2 941 124 € | 2 913 942 € | 34 048 € | 24 964 € |
| Total Assets | 3 873 843 € | 3 938 303 € | 4 110 272 € | 1 152 322 € | 1 064 641 € |
| Current Liabilities | 549 326 € | 603 786 € | 769 243 € | 635 106 € | 544 414 € |
| Non Current Liabilities | - | 3 853 € | 0 € | - | - |
| Total Liabilities | - | 607 639 € | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 3 324 517 € | 3 330 664 € | 3 341 029 € | 517 216 € | 520 227 € |
| Employees | 37 | 39 | 41 | 42 | 40 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 96 139.63 € | 58 726.48 € | 60 406.86 € | 29 |
| 2023 Q4 | 77 861.49 € | 65 692.44 € | 66 171.59 € | 37 |
| 2023 Q3 | 36 537.95 € | 73 543.67 € | 78 381.58 € | 38 |
| 2023 Q2 | 139 237.13 € | 89 472.2 € | 90 187.79 € | 46 |
| 2023 Q1 | 152 785.3 € | 97 156.14 € | 90 691.33 € | 46 |
| 2022 Q4 | 170 274.57 € | 93 999.03 € | 84 907.62 € | 50 |
| 2022 Q3 | 102 734.18 € | 91 788.75 € | 89 556.59 € | 47 |
| 2022 Q2 | 59 846.81 € | 82 454.95 € | 85 678.44 € | 51 |
| 2022 Q1 | 150 970.23 € | 99 842.35 € | 97 420.81 € | 50 |
| 2021 Q4 | 134 529.96 € | 96 260.29 € | 89 255.73 € | 52 |
| 2021 Q3 | 111 628.22 € | 92 828.31 € | 94 209.42 € | 52 |
| 2021 Q2 | 42 065.65 € | 77 761.47 € | 83 940.95 € | 52 |
| 2021 Q1 | 283 653.07 € | 113 033.51 € | 82 884.14 € | 49 |
| 2020 Q4 | 118 942.21 € | 75 830.91 € | 77 190.21 € | 47 |
| 2020 Q3 | 70 057.51 € | 80 981.61 € | 82 179.28 € | 45 |
| 2020 Q2 | 32 864.92 € | 54 916.04 € | 58 691.63 € | 45 |
| 2020 Q1 | 385 636.87 € | 112 293.52 € | 75 955.48 € | 45 |
